OBSTRUCTIVE SLEEP APNEA SYNDROME IN CONGESTIVE HEART FAILURE: CARDIOLOGIST PERSPECTIVE
https://doi.org/10.15829/1560-4071-2018-1-78-82
Abstract
In the review, the data presented, on sleep disordered respiration in chronic heart failure patients with emphazis on sleep apnea syndrome (SAS). The aspects of prevalence are discussed, as of pathogenesis, diagnostics and specifics of SAS management in decreased or normal ejection fraction. The original results presented, on the disordered breathing assessment in patients with severe systolic dysfunction. The necessity underscored for personalized diagnostic and management approach to obstructive sleep apnea syndrome which is not just a risk factor for heart failure, but is a comorbidity at various stages of cardiovascular continuum.
About the Authors
E. A. Medvedeva
Federal Almazov North-West Medical Research Centre of the Ministry of Health
Russian Federation
Russian Federation
Saint-Petersburg
L. S. Korostovtseva
Federal Almazov North-West Medical Research Centre of the Ministry of Health
Russian Federation
Russian Federation
Saint-Petersburg
Yu. V. Sazonova
Federal Almazov North-West Medical Research Centre of the Ministry of Health
Russian Federation
Russian Federation
Saint-Petersburg
M. V. Bochkarev
Federal Almazov North-West Medical Research Centre of the Ministry of Health
Russian Federation
Russian Federation
Saint-Petersburg
Yu. V. Sviryaev
Federal Almazov North-West Medical Research Centre of the Ministry of Health; Sechenov Institute of Evolution Physiology and Biochemistry
Russian Federation
Russian Federation
Saint-Petersburg
A. О. Konradi
Federal Almazov North-West Medical Research Centre of the Ministry of Health; Saint-Petersburg National Research University of Informational Technologies, Mechanics and Optics, Translational Medicine Institute
Russian Federation
Russian Federation
Saint-Petersburg
References
1. van Deursen VM, Urso R, Laroche C, et al. Comorbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 2014; 16: 103-11.
2. Steinberg BA, Zhao X, Heidenreich PA, et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 2012; 126: 65-75.
3. Kasai T, Bradley TD. Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J Am Coll Cardiol 2011; 57 (2): 119-27.
4. Mentz RJ, Fiuzat M. Sleep-Disordered Breathing in Patients with Heart Failure Heart Failure Clin 10 (2014) 243-50. DOI: 10.1016/j.hfc.2013.10.001.
5. Nakamura S, Asai K, Kubota Y, et al. Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleepdisordered breathing: a meta-analysis. Clin Res Cardiol 2015; 104: 208-16.
6. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC European Heart Journal. 2016; 37: 2129-200. DOI: 10.1093/eurheartj/ehw128.
7. Javaheri S, Caref EB, Chen E, et al. Sleep apnea testing and outcomes in a large cohort of medicare beneficiaries with newly diagnosed heart failure. Am J Respir Crit Care Med. 2011; 183: 539-46.
8. Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. J Clin Sleep Med. 2012; 8: 597-619.
9. White LH, Bradley TD. Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea. J Physiol 2013; 591 (5): 1179-93. DOI: 10.1113/jphysiol.2012.245159.
10. Cowie MR. Sleep-Disordered Breathing — Do We Have to Change Gears in Heart Failure? Curr Heart Fail Rep 2016; 13: 255-65. DOI: 10.1007/s11897-016-0304-x.
11. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005; 112: 2660-7.
12. Bitter T, Westerheide N, Prinz C, et al. Cheyne–Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter–defibrillator therapies in patients with congestive heart failure. Eur Heart J 2011; 32: 61-74.
13. Oliveira W, Campos O, Bezerra Lira-Filho E, et al. Left atrial volume and function in patients with obstructive sleep apnea assessed by real-time three-dimensional echocardiography. J AmSoc Echocardiogr 2008; 21: 1355-61.
14. Sekizuka H, Osada N, Miyake F. Sleep Disordered Breathing in Heart Failure Patients with Reduced versus Preserved Ejection Fraction. Heart Lung Circ 2013; 22: 104-9.
15. Herrscher TE, Akre H, Overland B, et al. High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. J Card Fail 2011; 17: 420-5.
16. Arikawa T, Toyoda S, Haruyama A, et al. Impact of Obstructive Sleep Apnoea on Heart Failure with Preserved Ejection Fraction. Heart, Lung and Circulation 2016; 25: 435-41. DOI: 10.1016/j.hlc.2015.09.011.
17. Gellen B, Canouï-Poitrine F, Boyer L, et al. Apnea–hypopnea and desaturations in heart failure with reduced ejection fraction: Are we aiming at the right target? Intern J Cardiol 2016; 203: 1022-8.
18. Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004; 169: 361-6.
19. Kasai T, Narui K, Dohi T, et al. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 2008; 133: 690-6.
20. Fiuzat M, Oldenberg O, Whellanc DJ, et al. Lessons learned from a clinical trial: Design, rationale, and insights from The Cardiovascular Improvements with Minute Ventilationtargete Adaptive Servo-Ventilation (ASV) Therapy in Heart Failure (CAT-HF) Study Contemporary Clinical Trials 2016; 47: 158-64. DOI: 10.1016/j.cct.2016.01.00.
21. Eulenburg C, Wegscheider K, Woehrle H, et al. Mechanisms underlying increased mortality risk in patients with heart failure and reduced ejection fraction randomly assigned to adaptive servoventilation in the SERVE-HF study: results of a secondary multistate modelling analysis. Lancet Respir Med 2016; 4: 873-81. DOI: 10.1016/S22132600(16)30244-2.
22. Takama N, Kurabayashi M. Safety and efficacy of adaptive servo-ventilation in patients with severe systolic heart failure. J Cardiol 2014; 63: 302-7. DOI: 10.1016/j.jjcc.2013.09.008.
23. Stanchina ML, Ellison K, Malhotra A, et al. The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot study. Chest 2007; 132 (2): 433-9.
24. Sekizuka Н, Osada N, Miyake F. Sleep Disordered Breathing in Heart Failure Patients with Reduced versus Preserved Ejection Fraction. Heart, Lung and Circulation 2013; 22: 104-9.
Review
For citations:
Medvedeva E.A., Korostovtseva L.S., Sazonova Yu.V., Bochkarev M.V., Sviryaev Yu.V., Konradi A.О. OBSTRUCTIVE SLEEP APNEA SYNDROME IN CONGESTIVE HEART FAILURE: CARDIOLOGIST PERSPECTIVE. Russian Journal of Cardiology. 2018;(1):78-82. (In Russ.) https://doi.org/10.15829/1560-4071-2018-1-78-82
Views:
2060
Email this article 